et
al
recent
report
possibl
causal
associ
novel
human
coronaviru
hcov
kawasaki
diseas
kd
report
respiratori
secret
patient
kd
agematch
control
subject
test
posit
hcov
design
esper
et
al
new
coronaviru
hcovnh
viru
report
close
relat
hcovnl
identifi
independ
group
netherland
determin
hcov
might
consist
associ
kd
analyz
nasopharyng
oropharyng
swab
sampl
collect
part
etiolog
investig
kd
san
diego
investig
focus
explor
possibl
causal
link
kd
chlamydia
pneumonia
detail
investig
casecontrol
design
describ
schrag
et
al
investig
complet
pharyng
swab
sampl
store
pharyng
swab
sampl
avail
analysi
patient
kd
control
subject
patient
onset
kd
februari
march
median
age
year
rang
year
patient
met
epidemiolog
case
definit
kd
fever
last
day
least
clinic
featur
kd
median
age
control
subject
year
rang
year
pharyng
swab
sampl
obtain
within
day
onset
ill
patient
kd
day
onset
ill
remain
patient
pharyng
swab
sampl
patient
kd
control
subject
test
neg
hcov
use
differ
primer
set
nucleic
acid
extract
pharyng
swab
sampl
use
autom
nuclisen
extractor
twentyfivemicrolit
reaction
contain
extract
nucleic
acid
prepar
access
rtpcr
system
promega
first
primer
set
use
amplif
primer
describ
esper
et
al
follow
modif
singl
nucleotid
degeneraci
introduc
sensestrand
primer
accommod
sequenc
variat
among
publish
sequenc
strain
underlin
indic
modif
amplif
program
consist
reversetranscript
rt
step
min
min
denatur
revers
transcriptas
cycl
min
min
min
min
final
amplicon
extens
second
chain
reaction
pcr
primer
set
broadli
reactiv
primer
design
target
highli
conserv
region
hcov
rna
polymeras
gene
sensestrand
primer
antisens
strand
primer
amplif
reaction
perform
describ
follow
program
set
use
rt
step
min
min
denatur
revers
transcriptas
cycl
min
min
min
min
final
amplicon
extens
sensestrand
primer
set
label
fluoresc
dye
end
facilit
amplicon
detect
predict
size
first
second
primer
set
bp
respect
use
ceq
genet
analysi
system
beckman
coulter
assay
perform
use
standard
viral
nucleic
acid
extract
hcov
nucleasefre
water
posit
neg
control
respect
pharyng
swab
sampl
test
posit
rtpcr
human
dehydrogenas
enzym
indic
adequ
recoveri
rna
sampl
rtpcr
inhibitor
absent
find
support
esper
et
al
methodolog
differ
type
time
sampl
collect
sampl
handl
storag
process
select
case
patient
control
subject
may
explain
differ
find
altern
differ
etiolog
agent
could
associ
kd
studi
popul
studi
includ
serolog
test
prospect
collect
highqual
pharyng
swab
sampl
may
need
determin
role
hcov
play
etiolog
kd
